PMCF Study on the Effectiveness and Safety of BIODENTOSS® and DWC® Dental Implants and Superstructures

Recruiting N/A Interventional Study
Tooth Loss Edentulism
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
80 (estimated)
Sponsor
Değirmenci Otomotiv ve Metal Endüstri A.Ş. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This prospective, single-center, interventional post-market clinical follow-up (PMCF) study aims to evaluate the early-term (24 months post-implantation) safety and efficacy of CE-marked BIODENTOSS® and DWC ® Dental Implants and Superstructures in patients requiring dental restoration for tooth loss.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18 years of age or older, * Male or female, * Subjects with missing tooth who require dental implant treatment, * At least 2 months elapsed since tooth extraction, * General health status suitable for implantation, * Not legally restricted (e.g., soldier, convict), * Provision…
Contacts

Abdullah Sari, Met. Eng.

+90 (332) 516 16 91

kaliteyonetimi@dome.com.tr

CONTACT